SFMBT2 and prostate cancer: In conclusion, our study provides evidence that the down-regulation of SFMBT2 promotes prostate cancer metastasis by the recruitment of preadipocytes and TAMs through NF-κB-dependent up-regulation of chemokine expression (Figure 7).